Tag: Abortion Pills

Medication abortion uses two FDA-approved oral medications to end a pregnancy: mifepristone and misoprostol, commonly referred to as “abortion pills.” Mifepristone interrupts the flow of the hormone progesterone that sustains the pregnancy, and misoprostol causes contractions to expel the contents of the uterus. You can use these pills in combination or use misoprostol alone.

Abortion pills are extremely safe. Serious adverse events occur in less than one-third of one percent of medication abortions. Abortion pills are over 95 percent effective when used within 10 weeks of the first day of your last menstrual period.

The organization Plan C has a comprehensive guide to finding abortion pills on their website at www.plancpills.org. Select “Find Abortion Pills” and then select the state where you are located from the drop-down menu. The website is continually updated and has all the latest information on where to find abortion pills from anywhere in the U.S.

Our Abortion Stories: ‘There Were No Resources Available to Make Choosing to Be a Single Mom a Sane Choice’

Abortions are sought by a wide range of people for many different reasons. There is no single story. Telling stories of then and now shows how critical abortion has been and continues to be for women and girls. (Share your abortion story by emailing myabortionstory@msmagazine.com.)

“I made a decision that deeply challenged my ‘values,’ yet was absolutely the most ethical and moral choice I could make.”

“I realized that I wasn’t the only one going through this, even though abortion stigma can oftentimes make us feel that way. … Your abortion is not a taboo or a deep, dark secret; abortion is healthcare.”

GenBioPro Appeals to Federal Court to Block West Virginia Abortion Ban 

GenBioPro, the nation’s only generic manufacturer of the abortion pill mifepristone, appealed the dismissal of a federal lawsuit challenging a West Virginia abortion ban that restricts access to the FDA-approved abortion medication mifepristone.

If successful, GenBioPro’s lawsuit could prevent states from banning mifepristone and could also protect access to other FDA-approved medications that have significant health benefits, such as vaccines.

The West Virginia court’s ruling could be helpful to people in states that still allow some abortions but block telemedicine abortion, such as Arizona, Florida, Georgia, Iowa, Kansas, Montana, Nebraska, Nevada, North Carolina, Ohio, Pennsylvania, South Carolina, Utah and Wisconsin. 

November 2023 Reads for the Rest of Us

Each month, we provide Ms. readers with a list of new books being published by writers from historically excluded groups.

This November brings a brilliant selection of new book releases. From Native American Heritage Month to Trans Day of Remembrance, there are books for you to learn from, unwind with, and reflect upon. Which of these 24 titles will you be reading this month?  

There’s Been a Major Increase in Abortion Pill Access—Thanks to COVID-19 and Dobbs

Over the last several years, in anticipation of the Supreme Court overturning Roe v. Wade and in response to the COVID pandemic, activists developed interstate telemedicine abortion services and community support networks that are now providing abortion pills to people living in all 50 states, including states with bans.

As a result, abortion pills are now more accessible and affordable than ever before.

‘Comstocked’: How Extremists Are Exploiting a Victorian-Era Law To Deny Abortion Access

In June 2019, the all-male city council in Waskom, Texas, unanimously voted to make the tiny town of just 2,000 residents the nation’s first “sanctuary city for the unborn.” Characterizing fetuses as the “most innocent among us [who] deserve equal protection under the law,” the ordinance expressly bans abortion within its municipal boundaries. The man behind the ban, anti-abortion zealot and pastor Mark Lee Dickson, has since expanded his campaign to outlaw abortion “one city at a time” into at least six other states.

(This article originally appears in the Fall 2023 issue of Ms. Join the Ms. community today and you’ll get issues delivered straight to your mailbox!)

Diverse Stakeholders Implore Supreme Court to Preserve Abortion Pill Access

On Thursday, Oct. 12, a wide range of organizations filed 14 amicus curiae briefs supporting a Justice Department petition asking the United States Supreme Court to overturn a Fifth Circuit decision imposing nationwide limits on access to the abortion pill mifepristone. 

The opposition has until Nov. 9 to file response briefs in the case. If the justices take up the case, they could hear oral arguments early next year and issue a decision by late June 2024, which would likely factor into the fall elections.

The Biden Administration’s Investment in Internet Will Reduce Barriers to Abortion

Millions of Americans lack access to reliable high-speed internet. But a move this summer from the Biden-Harris administration—a $42.45 billion investment in affordable high-speed internet—will no doubt help to close this digital divide. Promoting equity in internet access is especially urgent in a post-Roe world, where 21 states have moved to ban or restrict abortion, all while telehealth abortion capabilities are increasing.

The pandemic popularized and revolutionized telehealth, and today, a full range of reproductive healthcare services are available: abortion, contraception, gender-affirming care and more—but only if a person has reliable internet access. The Biden administration estimates 8.5 million households are without high-speed internet infrastructure, and millions more face limited or unreliable internet options.

Brick-and-Mortar Pharmacies Begin Dispensing Abortion Pills Across the U.S.

In January of 2023, the FDA announced the new certification process for pharmacies to dispense mifepristone. Last week, the pharmaceutical company GenBioPro announced the names of 18 brick-and-mortar pharmacies that are now dispensing the abortion pill mifepristone.

They are the first pharmacies to publicly acknowledge doing so after the FDA in late 2021 finally loosened medically unnecessary restrictions on mifepristone that blocked pharmacy distribution for decades.